Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018

Mutation of kvrA causes OmpK35/36 porin downregulation and reduced meropenem/vaborbactam susceptibility in KPC-producing Klebsiella pneumoniae.

(2020) Punyawee Dulyayangkul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

BacWGSTdb 2.0: a one-stop repository for bacterial whole-genome sequence typing and source tracking

(2020) Ye Feng et al.   NUCLEIC ACIDS RESEARCH

Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: epidemiology and genomic characterization

(2019) P. Gaibani et al.   CLINICAL MICROBIOLOGY AND INFECTION

Rectal screening of carbapenemase-producing Enterobacteriaceae: a proposed workflow

(2019) Claudio Foschi et al.   Journal of Global Antimicrobial Resistance

In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment

(2018) Paolo Gaibani et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clinical application of Bruker Biotyper MALDI-TOF/MS system for real-time identification of KPC production in Klebsiella pneumoniae clinical isolates

(2018) Paolo Gaibani et al.   Journal of Global Antimicrobial Resistance

Pitfalls of defining combination therapy for carbapenem-resistant Enterobacteriaceae in observational studies

(2017) D. R. Giacobbe et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections

(2017) Salvatore Piano et al.   GUT

Evaluation of Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of KPC-Producing Klebsiella pneumoniae

(2016) Paolo Gaibani et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Activity of Meropenem Combined with RPX7009, a Novel β-Lactamase Inhibitor, against Gram-Negative Clinical Isolates in New York City

(2015) Amabel Lapuebla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases

(2015) Scott J. Hecker et al.   JOURNAL OF MEDICINAL CHEMISTRY

β-Lactam/β-Lactamase Inhibitor Combinations

(2014) Kimberly A. Toussaint et al.   ANNALS OF PHARMACOTHERAPY

Identifying structural variation in haploid microbial genomes from short-read resequencing data using breseq

(2014) Jeffrey E Barrick et al.   BMC GENOMICS

Treating infections caused by carbapenemase-producing Enterobacteriaceae

(2014) L.S. Tzouvelekis et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014

(2014) M. Monaco et al.   Eurosurveillance

Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding

(2014) Liang Chen et al.   TRENDS IN MICROBIOLOGY

Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art

(2013) Nicola Petrosillo et al.   Expert Review of Anti-Infective Therapy

Klebsiella pneumoniae ST258 Producing KPC-3 Identified in Italy Carries Novel Plasmids and OmpK36/OmpK35 Porin Variants

(2012) Aurora García-Fernández et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Three Decades of  -Lactamase Inhibitors

(2010) S. M. Drawz et al.   CLINICAL MICROBIOLOGY REVIEWS

Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae

(2009) D. Landman et al.   JOURNAL OF MEDICAL MICROBIOLOGY